Apricus Biosciences Inc.

Company Website

11975 El Camino Real Ste., 300
San Diego, CA 92130

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Apricus Biosciences Inc.

Market Cap as of 6/12/2015

$82,175,608

Market Cap as of 7/03/2014

$84,038,259

Market Cap as of 07/02/2013

$84,047,623

Market Cap as of 06/26/2012

$87,021,790

Market Cap as of 01/04/2012

$107,333,600

Market Cap as of 06/20/2011

$99,467,980

Market Cap as of 01/06/2011

$63,863,860

Exchange and Ticker Symbol

Nasdaq: APRI

Fields of Research

Engages in the research and development of pharmaceutical drugs and drug candidates based on its proprietary NexACT drug delivery technology

Major Products

Vitaros, Totect, NitroMist, Granisol, Aquoral, MycoVa, PrevOnco, RayVa, Nupen

Executives

Bassam Damaj

  • Chairman
  • Chief Executive Officer
  • President

Related News

Articles

Taglich Brothers initiates coverage of Apricus

Taglich Bros. Inc., a brokerage firm specializing in microcap publicly traded securities, initiated coverage of San Diego-based Apricus Biosciences Inc.